MiMedx Group, Inc. expected to post a loss of 1 cent a share - Earnings Preview

• MiMedx Group, Inc. MDXG.O is expected to show a fall in quarterly revenue when it reports results on October 28 for the period ending September 30 2026

• The Marietta Georgia-based company is expected to report a 39.7% decrease in revenue to $68.553 million from $113.73 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.

• ​LSEG's mean analyst estimate for MiMedx Group, Inc. is for a loss of 1 cent per share.

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for MiMedx Group, Inc. is $8.00, about 107.8% above its last closing price of $3.85

The company's guidance on July 29 2026 for the period ended September 30 was for gross profit margin between 74% and 76%.

Previous quarterly performance (using preferred earnings measure in US dollars). ​

This summary was machine generated October 26 at 21:29 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)